Amicus Therapeutics slumps on new Fabry drug data Businessweek NEW YORK (AP) â" Shares of Amicus Therapeutics Inc. tumbled Friday after the company reported new negative results from a clinical trial of an experimental treatment for Fabry disease, a rare genetic disorder. Amicus said the drug, which is c » |
Nenhum comentário:
Postar um comentário